Alpha IVF Group opens its first satellite clinic in Indonesia,
expanding its regional footprint.
• Enhances accessibility for seamless cross-border fertility treatment
• Deepens presence in Southeast Asia’s high-growth fertility markets
KUALA LUMPUR, Malaysia, 5 May 2025 – Alpha IVF Group Berhad (“Alpha IVF Group”, “the Group”, “阿儿法国际辅助生殖集团”, Bloomberg: ALPHA MK, Bursa Ticker: 0303), a leading specialist in fertility care, today officially opened its first satellite clinic in Jakarta, Indonesia, further strengthening its presence in a key regional market.
Strategically located in North Jakarta’s vibrant Pantai Indah Kapuk (PIK) area, the new satellite clinic, Alpha Women’s Specialists – PIK, strengthens Alpha IVF Group’s presence in Indonesia. As a key touchpoint, the clinic completes the ecosystem of care for Indonesian patients by offering specialised women’s health services in fertility, obstetrics, and gynaecology, including hormonal assessments, follow-up care, and treatment for reproductive conditions like Polycystic Ovary Syndrome and endometriosis. It also serves as an educational gateway for the community, raising awareness of fertility issues and available treatment options.
This move reflects the Group’s steadfast commitment to easing the treatment journey for its patients by bringing essential services closer to home while maintaining clinical excellence through its flagship centres.
The Jakarta clinic is staffed by a dedicated, multidisciplinary team and is designed to provide personalized, high-quality care aligned with the Group’s exacting standards. While no forward-looking volume projections are disclosed, the Group anticipates the facility will contribute positively to its overall performance in the financial year ending 31 May 2026 (FY2026).
“Indonesia is one of the most dynamic IVF markets in the region, and we are proud to deepen our engagement by making our services more accessible. As a Group driven by clinical innovation and patient-first values, we will continue to deliver ethical, transparent, and effective care to families seeking hope through science.”
Dato’ Dr. Colin Lee Soon Soo (拿督 李顺树医生)
Group Managing Director, Alpha IVF Group
This initiative is part of Alpha IVF Group’s broader strategy to scale access to fertility treatment in high-demand, underserved regions while reinforcing its trusted reputation across Southeast Asia.
In FY2024, Indonesian patients contributed significantly to the Group’s international revenue, accounting for RM57.4 million or 42.38% of Malaysia operations revenue. This underscores the long-standing trust placed in Alpha IVF Group’s expertise by patients from Indonesia and across the region.
